Discover how innovative cell culture membrane inserts from Greiner Bio-One are revolutionizing drug development. In this article Philipp Wachter explains their role in enhance high-throughput screening studies and optimizing ADME studies for better drug evaluation.
Animal models are costly, time-consuming, and often have limited relevance to human biology. In this article, we’ll explain the advantages of magnetic 3D cell culture (M3D), why they are so useful, and how they are used in the laboratory – step-by-step.
Discover the power of high-content screening with high-performance imaging microplates. Learn how to optimize your screenings for accurate experimental results in this insightful article.
Kremsmünster, April 10, 2024 – Corinna Mitterschiffthaler took over the position of Director Division Human Resources at Greiner Bio-One on 2 April,…
Change of Management: Top Manager Saori Dubourg appointed new CEO
of Greiner AG
Your leading global partner in the fields of biotechnology, diagnostics, medial devices, in vitro diagnostics as well as in the world of research. Greiner Bio-One International GmbH is a global player with more than 2300 employees and 28 subsidiaries. We have production sites in Austria, Germany, Hungary, the United States, Brazil and Thailand. The headquarters of the public limited company, which is wholly owned by the Greiner family, is in Kremsmünster, Upper Austria. Greiner Bio-One International is a company of the Greiner Group. Our focus is on a strong customer orientation and innovative, top quality product solutions.
We would like to direct you to the correct site for your country.
